B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications

BACKGROUND: Vaccination campaign to contrast the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has raised the issue of vaccine immunogenicity in special populations such as people with multiple sclerosis (PwMS) on highly effective disease modifying treatments (DMTs). While h...

Descripción completa

Detalles Bibliográficos
Autores principales: Iannetta, Marco, Landi, Doriana, Cola, Gaia, Campogiani, Laura, Malagnino, Vincenzo, Teti, Elisabetta, Coppola, Luigi, Di Lorenzo, Andrea, Fraboni, Daniela, Buccisano, Francesco, Grelli, Sandro, Mozzani, Marcello, Zingaropoli, Maria Antonella, Ciardi, Maria Rosa, Nisini, Roberto, Bernardini, Sergio, Andreoni, Massimo, Marfia, Girolama Alessandra, Sarmati, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801814/
https://www.ncbi.nlm.nih.gov/pubmed/35111162
http://dx.doi.org/10.3389/fimmu.2021.796482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801814/
https://www.ncbi.nlm.nih.gov/pubmed/35111162
http://dx.doi.org/10.3389/fimmu.2021.796482

Ejemplares similares